Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Synthesis and photophysical properties of novel pyrene-metalloporphyrin dendritic systems.

Rojas-Montoya SM, Vonlanthen M, Porcu P, Flores-Rojas G, Ruiu A, Morales-Morales D, Rivera E.

Dalton Trans. 2019 Jul 16;48(28):10435-10447. doi: 10.1039/c9dt00855a.

PMID:
31123742
2.

Synthesis and Characterization of Clay Polymer Nanocomposites of P(4VP-co-AAm) and Their Application for the Removal of Atrazine.

Ramírez-Gómez JA, Illescas J, Díaz-Nava MDC, Muro-Urista C, Martínez-Gallegos S, Rivera E.

Polymers (Basel). 2019 Apr 19;11(4). pii: E721. doi: 10.3390/polym11040721.

3.

Energy Transfer in Dendritic Systems Having Pyrene Peripheral Groups as Donors and Different Acceptor Groups.

Porcu P, Vonlanthen M, Ruiu A, González-Méndez I, Rivera E.

Polymers (Basel). 2018 Sep 25;10(10). pii: E1062. doi: 10.3390/polym10101062. Review.

4.

Cervical fusion for degenerative disease: A comprehensive cost analysis of hospital complications in the United States from 2002 to 2014.

Deng H, Yue JK, Ordaz A, Rivera EJ, Suen CG, Sing DC.

J Craniovertebr Junction Spine. 2018 Jul-Sep;9(3):140-147. doi: 10.4103/jcvjs.JCVJS_62_18.

5.

Design of Novel Pyrene-Bodipy Dyads: Synthesis, Characterization, Optical Properties, and FRET Studies.

Porcu P, Vonlanthen M, González-Méndez I, Ruiu A, Rivera E.

Molecules. 2018 Sep 7;23(9). pii: E2289. doi: 10.3390/molecules23092289.

6.

Temporal lobe contusions on computed tomography are associated with impaired 6-month functional recovery after mild traumatic brain injury: a TRACK-TBI study.

Yue JK, Winkler EA, Puffer RC, Deng H, Phelps RRL, Wagle S, Morrissey MR, Rivera EJ, Runyon SJ, Vassar MJ, Taylor SR, Cnossen MC, Lingsma HF, Yuh EL, Mukherjee P, Schnyer DM, Puccio AM, Valadka AB, Okonkwo DO, Manley GT, The Track-Tbi Investigators.

Neurol Res. 2018 Nov;40(11):972-981. doi: 10.1080/01616412.2018.1505416. Epub 2018 Sep 3.

PMID:
30175944
7.

Electrochemical Characterization of Single Lithium-Ion Conducting Polymer Electrolytes Based on sp3 Boron and Poly(ethylene glycol) Bridges.

Guzmán-González G, Ávila-Paredes HJ, Rivera E, González I.

ACS Appl Mater Interfaces. 2018 Sep 12;10(36):30247-30256. doi: 10.1021/acsami.8b02519. Epub 2018 Aug 30.

PMID:
30113816
8.

Transformations in Chemically Responsive Copper-Calixarene Architectures.

Percástegui EG, Reyes-Mata C, Flores-Alamo M, Quiroz-García B, Rivera E, Castillo I.

Chem Asian J. 2018 Mar 2;13(5):520-527. doi: 10.1002/asia.201701741. Epub 2018 Feb 5.

PMID:
29316352
9.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

10.

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L; DAPT Study Investigators.

JAMA. 2016 Apr 26;315(16):1735-49. doi: 10.1001/jama.2016.3775. Erratum in: JAMA. 2016 Jul 19;316(3):350. JAMA. 2016 Jul 19;316(3):350.

11.

Crystal structure of 2-(thio-phen-3-yl)ethyl pyrene-1-carboxyl-ate.

Valderrama-García BX, Reyes-Martínez R, Hernández-Ortega S, Morales-Morales D, Rivera E.

Acta Crystallogr E Crystallogr Commun. 2015 Nov 11;71(Pt 12):o926-7. doi: 10.1107/S2056989015020873. eCollection 2015 Dec 1.

12.

Synthesis and Characterization of Novel Polythiophenes Containing Pyrene Chromophores: Thermal, Optical and Electrochemical Properties.

Valderrama-García BX, Rodríguez-Alba E, Morales-Espinoza EG, Moineau Chane-Ching K, Rivera E.

Molecules. 2016 Jan 30;21(2):172. doi: 10.3390/molecules21020172.

13.

One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).

Ohki T, Angle JF, Yokoi H, Jaff MR, Popma J, Piegari G, Kanaoka Y; OSPREY investigators.

J Vasc Surg. 2016 Feb;63(2):370-6.e1. doi: 10.1016/j.jvs.2015.08.093. Epub 2015 Oct 17.

14.

Conformation of Novel Azo-Dyes Bearing End-Capped Oligo(ethylene glycol) Studied by UV-vis and NMR Spectroscopy.

Kouvatas C, Baille WE, Ortíz-Palacios J, Aguilar-Ortíz E, Rivera E, Zhu XX.

J Phys Chem B. 2015 Sep 17;119(37):12318-24. doi: 10.1021/acs.jpcb.5b05853. Epub 2015 Sep 1.

PMID:
26301754
15.

Supramolecular fluorescence enhancement via coordination-driven self-assembly in bis-picolylcalixarene blue-emitting M2L2Xn macrocycles.

Guzmán-Percástegui E, Vonlanthen M, Quiroz-García B, Flores-Alamo M, Rivera E, Castillo I.

Dalton Trans. 2015 Sep 28;44(36):15966-75. doi: 10.1039/c5dt02058a.

PMID:
26281769
16.

Crystal structure of 1-meth-oxy-pyrene.

Morales-Espinoza EG, Rivera E, Reyes-Martínez R, Hernández-Ortega S, Morales-Morales D.

Acta Crystallogr E Crystallogr Commun. 2015 Feb 28;71(Pt 3):o210-1. doi: 10.1107/S2056989015003783. eCollection 2015 Mar 1.

17.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators.

JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671. Erratum in: JAMA. 2015 Jun 2;313(21):2185. JAMA. 2016 Jul 5;316(1):105. JAMA. 2016 Jul 5;316(1):105.

18.

S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes.

Gray WA, Feiring A, Cioppi M, Hibbard R, Gray B, Khatib Y, Jessup D, Bachinsky W, Rivera E, Tauth J, Patarca R, Massaro J, Stoll HP, Jaff MR; STROLL Study Investigators.

J Vasc Interv Radiol. 2015 Jan;26(1):21-8. doi: 10.1016/j.jvir.2014.09.018. Epub 2014 Nov 15.

PMID:
25454735
19.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators.

N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16.

20.

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.

Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators.

JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321.

PMID:
24682069

Supplemental Content

Loading ...
Support Center